The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy-Reference-Cited by-同舟云学术

The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy

Published:2006-01 Issue:2 Volume:7 Page:82-90
ISSN:1562-2975
Container-title:The World Journal of Biological Psychiatry
language:en
Short-container-title:The World Journal of Biological Psychiatry

Author:

Baghai Thomas C.,Marcuse Alain,Brosch Melanie,Schüle Cornelius,Eser Daniela,Nothdurfter Caroline,Steng Yvonne,Noack Ines,Pietschmann Katrin,Möller Hans-Jürgen,Rupprecht Rainer

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

http://www.tandfonline.com/doi/pdf/10.1080/15622970500213871

Reference42 articles.

1. Stimulus Titration and ECT Dosing

2. Antidepressant Effects of High-Dose Right Unilateral Electroconvulsive Therapy

3. Prolonged bradycardia complicates antidepressive treatment with venlafaxine and ECT

4. Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Electroencephalography Seizure Duration Account for an Adequate Treatment of Magnetic Seizure Therapy for Schizophrenia?;The Journal of ECT;2024-08-21

2. The influence of concomitant antidepressant and antipsychotic medication on antidepressant effect and seizure duration of electroconvulsive therapy;Frontiers in Psychiatry;2024-03-18

3. The influence of anaesthetic choice on seizure duration of electroconvulsive therapy; etomidate versus methohexital;BMC Anesthesiology;2022-07-05

4. Influence of adjuvant nortriptyline on the efficacy of electroconvulsive therapy: A randomized controlled trial and 1‐year follow‐up;Acta Psychiatrica Scandinavica;2022-02-18

5. Therapieresistenz unipolarer depressiver Erkrankung: Definition, Häufigkeit, Charakteristika, Prädiktoren und Risikofaktoren;Therapieresistenz bei Depressionen und bipolaren Störungen;2022